
Otsuka Canada Pharmaceutical Inc. is an innovative, fast-growing health care company, (owned and controlled by Otsuka America Pharmaceutical, Inc., one of the Otsuka Group of Companies) that commercializes Otsuka medicines in Canada, with a focus on and commitment to neuroscience, cardiovascular, oncology and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life. OCPI is part of the Otsuka Group, and was established in 2010, with headquarters in Saint-Laurent, Quebec.
Contact
Address: 2250 Bd Alfred Nobel, Saint-Laurent, QC H4S 2C9, Canada
Tel: +1 514 332 3001
Website: http://otsukacanada.com/